国际白癜风工作组全球专家建议:第2部分——具体治疗推荐
该共识声明由42名国际白癜风专家与4名患者代表参与制定,通过线上和线下会议形成白癜风治疗的管理策略。推荐汇总了局部治疗(激素、钙调神经磷酸酶抑制剂及JAK抑制剂)、系统性治疗(激素及其他免疫调节或抗氧化剂)和光疗(NB-UVB、光化学治疗、准分子设备及家庭光疗)的最新证据,并涉及介入治疗、脱色策略及在研创新靶向治疗。
要点
- 共识推荐涵盖局部激素、钙调神经磷酸酶抑制剂及JAK抑制剂等外用治疗。
- 系统性治疗包括激素及其他免疫调节或抗氧化剂。
- 光疗方式包括NB-UVB、光化学治疗、准分子设备及家庭光疗,常与其他治疗联合。
核心结论
- 该国际共识声明形成了针对白癜风治疗的专家循证临床实践推荐。
- 白癜风新疗法的研发仍在进行,未来可能改善该病的治疗管理。
研究设计与样本
- 共识声明,由42名国际白癜风专家和4名患者代表参与,通过线上和线下会议制定共识管理策略。
主要发现
- 推荐总结了局部治疗(激素、钙调神经磷酸酶抑制剂及JAK抑制剂)、系统性治疗(激素、其他免疫调节或抗氧化剂)及光疗(NB-UVB、光化学治疗、准分子设备、家庭光疗)的最新证据。
- 还纳入了介入治疗、脱色策略及在研创新靶向治疗的现状。
临床怎么用
- 推荐可作为白癜风临床管理中局部治疗、系统性治疗、光疗、介入治疗及脱色策略的专家参考。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The treatment of vitiligo can be challenging. Up-to-date agreed consensus recommendations on the use of topical and systemic therapies to facilitate the clinical management of vitiligo are currently lacking. OBJECTIVES: To develop internationally agreed-upon expert-based recommendations for the treatment of vitiligo. METHODS: In this consensus statement, a consortium of 42 international vitiligo experts and four patient representatives participated in different online and live meetings to develop a consensus management strategy for vitiligo. At least two vitiligo experts summarized the evidence for different topics included in the algorithms. A survey was then given to a core group of eight experts to resolve the remaining issues. Subsequently, the recommendations were finalized and validated based on further input from the entire group during two live meetings. RESULTS: The recommendations provided summarize the latest evidence regarding the use of topical therapies (steroids, calcineurin inhibitors and Jak-inhibitors) and systemic therapies, including steroids and other systemic immunomodulating or antioxidant agents. The different modalities of phototherapies (NB-UVB, photochemotherapy, excimer devices and home phototherapy), which are often combined with other therapies, are also summarized. Interventional approaches as well as depigmentation strategies are presented for specific indications. Finally, the status of innovative and targeted therapies under development is discussed. CONCLUSIONS: This international consensus statement culminated in expert-based clinical practice recommendations for the treatment of vitiligo. The development of new therapies is ongoing in vitiligo, and this will likely improve the future management of vitiligo, a disease that still has many unmet needs.
引用
- Seneschal J, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations. J Eur Acad Dermatol Venereol. 2023. PMID: 37715487. doi:10.1111/jdv.19450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。